<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:2.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;
	font-weight:normal;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-GB>

<div class=WordSection1>

<h1><span style='font-size:15.0pt;line-height:107%'>2010A01 Describe how the
chemical structure of local anaesthetic drugs determines their efficacy and
safety.</span></h1>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p>

<h3><span style='font-size:13.0pt;line-height:107%'>List:</span></h3>

<p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Intro</p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Lipophilic part</p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Link</p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Hydrophilic part</p>

<p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:0in;
margin-bottom:0in;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Other: isomerism, ionisation</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p>

<h3><span style='font-size:13.0pt;line-height:107%'>Intro:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Local anaesthetic structure</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Lipophilic group</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Chain: ester or amide bond and hydrocarbon chain</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Hydrophilic group</p>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'><img width=238 height=113 id="Picture 1"
  src="2010A01_local%20anaesthetics_structure_activity_relationships_files/image001.jpg"></p>
  </td>
 </tr>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Determinant of efficacy</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;line-height:
  normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Propensity for blockade of neuronal voltage-dependent Na+
  channel (VDNaC)</p>
  </td>
 </tr>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Determinant of toxicity</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;line-height:
  normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Propensity for blockade of VDNaC in the CNS (excitation then depression)
  and myocardium (conduction delay, re-entrant arrhythmia, arrest)</p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p>

<h3><span style='font-size:13.0pt;line-height:107%'>Lipophilic part:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Purpose</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>For crossing axonal membrane</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>For local anaesthetic activity</p>
  </td>
 </tr>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Structure</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;line-height:
  normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Usually an aromatic ring</p>
  </td>
 </tr>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Factors influenced</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Lipophilicity</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Potency</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Duration</p>
  </td>
 </tr>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Examples</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Ester:</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:25.95pt;margin-bottom:.0001pt;text-indent:-4.5pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span>Metabolite PABA may
  cause hypersensitivity</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:25.95pt;margin-bottom:.0001pt;text-indent:-4.5pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span>Excreted unchanged
  in urine; could accumulate in renal failure</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Prilocaine:</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:25.95pt;margin-bottom:.0001pt;text-indent:-4.5pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span>Metabolite
  O-toluidine may cause methaemoglobinaemia</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:25.95pt;margin-bottom:.0001pt;text-indent:-4.5pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span>Oxidises Fe<sup>2+</sup>
  in Hb</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:25.95pt;margin-bottom:.0001pt;text-indent:-4.5pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span>Significant if
  &gt;600mg prilocaine given to adult. PABA excreted in urine</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Chlorprocaine:</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:25.95pt;margin-bottom:.0001pt;text-indent:-4.5pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span>Cl atom &#8593;rate
  of ester hydrolysis 3.5x -&gt; &#8595;risk toxicity</p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p>

<h3><span style='font-size:13.0pt;line-height:107%'>Link:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Ester bond</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>O=COR</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Metabolized rapidly in plasma/liver by pseudocholinesterase</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>&#8595;peak plasma [LA] -&gt; &#8595;risk toxicity (hence
  prilocaine used for Bier’s block)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Products: aromatic acid + alcohol + tertiary amide</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>&#8593;Length alcohol -&gt; &#8593;potency up to a critical
  length, then &#8593;toxicity</p>
  </td>
 </tr>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Amide bond</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>NHC=OR</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Metabolized slowly in liver by amidases (CYP450)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>&#8593;peak plasma [LA] -&gt; &#8593;risk toxicity</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>Agent-specific metabolites</p>
  </td>
 </tr>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Hydrocarbon chain</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:7.95pt;margin-bottom:.0001pt;text-indent:-7.95pt;line-height:
  normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span>&#8593;length of chain -&gt; &#8593;potency</p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p>

<h3><span style='font-size:13.0pt;line-height:107%'>Hydrophilic part:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Purpose</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:12.6pt;margin-bottom:.0001pt;text-indent:-9.0pt;line-height:
  normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span>For water dissolution</p>
  </td>
 </tr>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Structure</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:12.6pt;margin-bottom:.0001pt;text-indent:-9.0pt;line-height:
  normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span>Usually tertiary amine e.g. diethylamine</p>
  </td>
 </tr>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Determinant of</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:12.6pt;margin-bottom:.0001pt;text-indent:-9.0pt;line-height:
  normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span>Lipid solubility (LS) <span style='font-family:"Cambria Math",serif'>&#8733;</span>
  potency <span style='font-family:"Cambria Math",serif'>&#8733;</span>
  toxicity</p>
  </td>
 </tr>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Examples: pipecolyxylidides</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Structure-activity relationships:</p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:12.6pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span>Chiral due to assymetric carbon (cf. lignocaine)</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:12.6pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span>Length piperidine C-chain <span style='font-size:12.0pt;
  font-family:"Cambria Math",serif;color:#222222;background:white'>&#8733;</span>
  lipid solubility, potency, toxicity, % protein bound</p>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Comparisons (reference: procaine)</p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:12.6pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span>Methyl (CH<sub>3</sub>) = mepiv</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:35.1pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span>LS 100x, potency 2x, 77%
  plasma protein bound (PPB))</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:12.6pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span>Propyl (C<sub>3</sub>H<sub>7</sub>) = ropiv</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:35.1pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span>LS 300x, potency 8x, 94%
  PPB)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:35.1pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span>S-ropiv more potent, less
  toxic, hence always enantiopure</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:12.6pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span>Butyl (C<sub>4</sub>H<sub>9</sub>) = bupiv</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:35.1pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span>LS 1000x, potency 8x, 95%
  PPB</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:35.1pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span>L-bupiv more potent, less
  toxic, preferred in paeds (expensive)</p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p>

<h3><span style='font-size:13.0pt;line-height:107%'>Other:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Isomerism</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0in;margin-right:0in;margin-bottom:
  0in;margin-left:12.6pt;margin-bottom:.0001pt;text-indent:-9.0pt;line-height:
  normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span>e.g. S-ropivacaine more potent, less toxic than R-ropivacaine</p>
  </td>
 </tr>
 <tr>
  <td width=120 valign=top style='width:89.75pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal'>Ionisation</p>
  </td>
  <td width=481 valign=top style='width:361.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:12.6pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
  </span></span>Determines diffusability hence speed of onset</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:35.1pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span>e.g. lignocaine pKa 7.9,
  25% unionised at pH 7.4 -&gt; fast onset</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0in;margin-right:0in;
  margin-bottom:0in;margin-left:35.1pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span>e.g. bupivacaine pKa 8.1,
  15% unionised at pH 7.4 -&gt; medium onset</p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt'>&nbsp;</p>

</div>

</body>

</html>
